Phase 3 Gastric Adenocarcinoma Clinical Trials
13 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–13 of 13 trials
Recruiting
Phase 2Phase 3
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+13 more
National Cancer Institute (NCI)224 enrolled370 locationsNCT06203600
Recruiting
Phase 3
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Global Development, Inc.500 enrolled224 locationsNCT06901531
Recruiting
Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction AdenocarcinomaMetastatic Gastric Adenocarcinoma
BeOne Medicines351 enrolled85 locationsNCT07043400
Recruiting
Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+12 more
Alliance for Clinical Trials in Oncology382 enrolled791 locationsNCT05677490
Recruiting
Phase 2Phase 3
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Gastroesophageal Junction AdenocarcinomaPeritoneal CarcinomatosisGastric Adenocarcinoma
ECOG-ACRIN Cancer Research Group148 enrolled10 locationsNCT07001748
Recruiting
Phase 3
Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Metastatic Oesogastric Adenocarcinoma
Federation Francophone de Cancerologie Digestive324 enrolled64 locationsNCT07270991
Recruiting
Phase 3
Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer
Gastric AdenocarcinomaComplicationsLaparoscopic Gastrectomy
Zuoyi Jiao454 enrolled6 locationsNCT07029269
Recruiting
Phase 3
A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-positive Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction Adenocarcinoma
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd.490 enrolled2 locationsNCT07152405
Recruiting
Phase 3
A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
Gastric Adenocarcinoma
Suzhou Immunofoco Biotechnology Co., Ltd150 enrolled1 locationNCT07103668
Recruiting
Phase 2Phase 3
[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer
Locally Advanced Gastric Adenocarcinoma
Leiden University Medical Center250 enrolled10 locationsNCT07018661
Recruiting
Phase 3
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Hepatocellular CarcinomaGastric AdenocarcinomaPancreatic Adenocarcinoma+4 more
Georgetown University20 enrolled3 locationsNCT05482516
Recruiting
Phase 3
PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer
Oligometastatic Gastric Adenocarcinoma
Azienda Ospedaliera Universitaria Integrata Verona98 enrolled1 locationNCT05303714
Recruiting
Phase 3
Study of Comparing of With and Without Sequential Therapy of S-1
Locally Advanced Gastric AdenocarcinomaChemotherapy Effect
Zhejiang University70 enrolled1 locationNCT05813015